Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
57
57 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- IanalumabVAY736, VAY736 AIPhase 318 trials
Novartis · Primary Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus, Sjogren Syndrome
- GlucocorticoidsPhase 37 trials
Novartis · VEXAS Syndrome, ANCA Associated Vasculitis (AAV), Anti-Glomerular Basement Membrane Disease
- PelacarsenTQJ230Phase 37 trials
Novartis · Cardiovascular Disease and Lipoprotein(a), Atherosclerotic Cardiovascular Disease (ASCVD), Atherosclerotic Cardiovascular Disease
- FUB523zigakibart, BION-1301Phase 36 trials
Novartis · IgA Nephropathy, Immunoglobulin A Nephropathy, IgA Nephropathy (IgAN)
- PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease
- KLU156Phase 34 trials
Novartis · Uncomplicated Plasmodium Falciparum Malaria
- PelabresibDAK539, CPI-0610Phase 34 trials
Novartis · Myelofibrosis, Primary Myelofibrosis, Primary Myelofibrosis (PMF)
- 177Lu-PSMA-617Lutetium [177Lu] vipivotide tetraxetan, lutetium vipivotide tetraxetanPhase 33 trials
Novartis · Prostatic Neoplasms, Prostatic Neoplasm, Metastatic Castration Resistant Prostate Cancer (mCRPC)
- AbelacimabMAA868Phase 33 trials
Anthos Therapeutics, Inc. · Atrial Fibrillation (AF), Stroke
- PacibekitugTOUR006, PAC001Phase 33 trials
Tourmaline Bio, Inc., a Novartis Company · Myocardial Infarction, Thyroid Eye Disease, Chronic Kidney Diseases
- [68Ga]Ga-DOTA-TATEAAA501Phase 32 trials
Novartis · Extensive Stage Small Cell Lung Cancer, Neuroendocrine Neoplasms
- AAA817[225Ac]Ac-PSMA-617Phase 32 trials
Novartis · Prostate Cancer
- ARDTPhase 32 trials
Novartis · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
- ARPI: EnzalutamideARPI abirateronePhase 32 trials
Novartis · Metastatic Castration Resistant Prostate Cancer (mCRPC), Prostate Cancer
- NaporafenibLXH254, ERAS-254Phase 32 trials
Novartis · Melanoma, Advanced or Metastatic NRAS-mutant Melanoma
- QMF149Phase 31 trial
Novartis · Asthma
- QVM149Phase 31 trial
Novartis · Asthma
- rapcabtagene autoleucelYTB323Phase 28 trials
Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)
- KAE609CipargaminPhase 25 trials
Novartis · Uncomplicated Plasmodium Falciparum Malaria, Severe Malaria
- luxdegalutamideJSB462, ARV-766Phase 24 trials
Novartis · Prostatic Cancer, Castration-Resistant, Progressive Metastatic Castrate Resistant Prostate Cancer, Prostate Cancer Metastatic
- MAS825ArumakimigPhase 24 trials
Novartis · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations, Still´s Disease, VEXAS Syndrome
- DDY391Phase 23 trials
Novartis · Moderate to Severe Psoriatic Arthritis, Sjögren's Disease
- GIA632Phase 23 trials
Novartis · Atopic Dermatitis, Non-segmental Vitiligo, Cutaneous Lichen Planus
- INE963Phase 23 trials
Novartis · Uncomplicated Plasmodium Falciparum Malaria
- JDQ443OpnurasibPhase 23 trials
Novartis · Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation, Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation
- QCZ484Phase 23 trials
Novartis · Hypertension (HTN), Hypertension, Hypercholesterolaemia
- TulmimetostatDZR123, Tulmimetostat DL1Phase 23 trials
Novartis · Progressive Metastatic Castrate Resistant Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Advanced Solid Tumor
- [177Lu]Lu-NeoBLutetium NeoB, [177Lu]-NeoBPhase 22 trials
Novartis · Breast Cancer, Neoplasms
- [68Ga]Ga-NeoBGallium NeoB, [68Ga]-NeoBPhase 22 trials
Novartis · Breast Cancer, Neoplasms
- DFV890Phase 22 trials
Novartis · Coronary Heart Disease, Symptomatic Knee Osteoarthritis
- TNO155Phase 22 trials
Novartis · Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation, KRAS G12C Mutant Solid Tumors
- VHB937Phase 22 trials
Novartis · Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease
- AMO959BY1298, BY101298Phase 21 trial
Novartis · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
- CPK850Phase 21 trial
Novartis · Retinitis Pigmentosa
- DII235Phase 21 trial
Novartis · Lipoprotein Disorder
- DJI136Phase 21 trial
Novartis · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
- DYP688Phase 21 trial
Novartis · Metastatic Uveal Melanoma
- ECI830Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
- EDI048Phase 21 trial
Novartis · Cryptosporidiosis
- EYU688Phase 21 trial
Novartis · Dengue
- FWY003Phase 21 trial
Novartis · Geographic Atrophy Secondary to Age-related Macular Degeneration
- GHZ339Phase 21 trial
Novartis · Atopic Dermatitis
- GVV858Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
- GXV813Phase 21 trial
Novartis · Schizophrenia
- iscalimabCFZ533Phase 21 trial
Novartis · Hidradenitis Suppurativa
- ITU512Phase 21 trial
Novartis · Sickle Cell Disease
- LTT462Phase 21 trial
Novartis · Melanoma
- LXE408Phase 21 trial
Novartis · Chagas Disease
- LYS006Phase 21 trial
Novartis · Hidradenitis Suppurativa
- NazartinibEGF816Phase 21 trial
Novartis · Advanced Solid Tumors Which Are cMET-dependent
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.